BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16849416)

  • 1. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
    Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
    Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
    Goodarzi MO; Antoine HJ; Azziz R
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
    Antoine HJ; Pall M; Trader BC; Chen YD; Azziz R; Goodarzi MO
    Fertil Steril; 2007 Apr; 87(4):862-9. PubMed ID: 17141766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
    Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.
    Xu N; Taylor KD; Azziz R; Goodarzi MO
    Fertil Steril; 2010 Jun; 94(1):255-60.e1-2. PubMed ID: 19327767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5alpha-reductase activity in women with polycystic ovary syndrome.
    Jakimiuk AJ; Weitsman SR; Magoffin DA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2414-8. PubMed ID: 10404813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
    Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic hirsutism: local and peripheral expression of aromatase (CYP19A) and 5α-reductase genes (SRD5A1 and SRD5A2).
    Caglayan AO; Dundar M; Tanriverdi F; Baysal NA; Unluhizarci K; Ozkul Y; Borlu M; Batukan C; Kelestimur F
    Fertil Steril; 2011 Aug; 96(2):479-82. PubMed ID: 21676395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First evidence of genetic association between AKT2 and polycystic ovary syndrome.
    Goodarzi MO; Jones MR; Chen YD; Azziz R
    Diabetes Care; 2008 Dec; 31(12):2284-7. PubMed ID: 18768676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.
    Shah NA; Antoine HJ; Pall M; Taylor KD; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2008 May; 93(5):1939-45. PubMed ID: 18303071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
    Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
    Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of male pattern baldness and the 5alpha-reductase genes.
    Ellis JA; Stebbing M; Harrap SB
    J Invest Dermatol; 1998 Jun; 110(6):849-53. PubMed ID: 9620288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.
    Eriksen MB; Brusgaard K; Andersen M; Tan Q; Altinok ML; Gaster M; Glintborg D
    Eur J Obstet Gynecol Reprod Biol; 2012 Jul; 163(1):39-42. PubMed ID: 22504079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
    Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
    Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.